Immunoreactive Plasma Cholinesterase (EC 3.1.1.8) Substance Concentration, Compared with Cholinesterase Activity Concentration and Albumin: Inter- and Intra-Individual Variations in a Healthy Population Group
- 1 January 1990
- journal article
- research article
- Published by Walter de Gruyter GmbH in cclm
- Vol. 28 (11) , 851-856
- https://doi.org/10.1515/cclm.1990.28.11.851
Abstract
Substance concentrations of plasma cholinesterase (EC 3.1.1.8) were measured in 94 healthy individuals without occupational exposure to known inhibitors (six samples from each individual). Immunoreactive cholinesterase substance concentrations showed an inter-individual variation corresponding to CVtotal = 22% (mean 5.01 mg/l, SD mg/l mg/l). Intra-individual variations of immunoreactive cholinesterase substance concentration were correlated (r = 0.36) to intra-individual variations of albumin. Estimated by a repeated-measures analysis of variance, the observed intra-individual variation of cholinesterase substance concentration corresponded to CV = 8.8% (SD: 0.44 mg/l), which toghether with a CVerror = 6% (within and between runs), implies a biological intra-individual variation of cholinesterase substance concentration corresponding to CVintra = 6.4%. Specific catalytic activity (kU/mg immunoreactive cholinesterase) was influenced by the ChE-1 phenotype (phenotype U: 1.58 kU/mg, phenotype UA: 1.22 kU/mg), but not by body weight, height, age, and sex. Observed intra-individual variation of specific catalytic corresponded to 6.4% (SD: 0.10 kU/mg), which together with an estimated CVerror - 6.2 implies tha biological intra-individual variations of specific catalytic cholinesterase activity to be insignificant. The insignificant CVintra makes specific catalytic cholinesterase activity a rational quantity for evaluation of unexpected fluctuations of cholinesterase activity concentrations.This publication has 24 references indexed in Scilit:
- Plasma cholinesterase activity in a healthy population group with no occupational exposure to known cholinesterase inhibitors: relative influence of some factors related to normal inter- and intra-individual variationsScandinavian Journal of Clinical and Laboratory Investigation, 1990
- Effect of Body Mass and other Factors on Serum Liver Enzyme Levels in Men Attending for Well Population ScreeningAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1989
- Identification of the structural mutation responsible for the dibucaine-resistant (atypical) variant form of human serum cholinesterase.Proceedings of the National Academy of Sciences, 1989
- Structure of human serum cholinesteraseBioEssays, 1988
- Brain cDNA clone for human cholinesterase.Proceedings of the National Academy of Sciences, 1987
- Desirable Performance Standards for Clinical Chemistry TestsPublished by Elsevier ,1983
- The Plasma Cholinesterases: A New PerspectivePublished by Elsevier ,1981
- Comparison of atypical and usual human serum cholinesterase. Purification, number of active sites, substrate affinity, and turnover number.Journal of Biological Chemistry, 1978
- Enzyme Characterization in Quantitative ImmunoelectrophoresisScandinavian Journal of Immunology, 1975
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951